[retrospective and comparative study of pneumococcal bacteremia in patients with chronic hepatopathy]

NLM AIDSLINE [Retrospective and comparative study of pneumococcal bacteremia in patients with chronic hepatopathy] Ramos Rincon JM; Cuenca Estrella M; Fernandez Guerrero ML; Servicio de
February 28, 1997

An Med Interna. 1996 Jul;13(7):313-6. Unique Identifier : AIDSLINE BACKGROUND: The chronic hepatopathy predispose to severe infections due to Streptococcus pneumoniae, including bacteremia. METHODS: We have reviewed the clinic characteristics and outcome of 34 patients without HIV infection and compared with 140 HIV-negative patients with pneumococcal bacteremia. RESULTS: From 34 patients with chronic liver diseases, 27 were male (79%) and 7 female (21%), aged from 33 to 83 years. In 16 cases the origin of hepatopathy were alcoholic. The majority of the patients had fever (85%). From 29 isolations of S. pneumoniae in which a sensibility study was available, 5 (17%) were resistant to penicillin. Among 27 (79%) cases of chronic hepatopathy, the bacteremia was associated with pneumonia; 5 (18%) cases had roentgenographic evidence of multiple-lobe involvement, and 6 (18%) had peritonitis. The independent factors associated with pneumococcal bacteremia in chronic hepatopathy patients were elevated concentrations of amino-transferases (p < 0.001), alcoholism (p < 0.001) and bacteremic peritonitis (p = 0.007). The overall case of fatality and bacteremia-related mortality rate were higher among patients with chronic hepatopathy than control group, without statistic signification (38% vs 25%; and 29% vs 24% of control group, respectively). The presence of septic shock was poor prognosis (mortality rate: 83% [10/12]; p < 0.001). The multilobar involvement was associated with high mortality rate (60%; p = 0.1). CONCLUSIONS: Pneumococcal bactermia in patients with chronic hepatopathy have a high mortality rate; however clinical outcome is similar to patients without chronic hepatopathy. Adult Aged Aged, 80 and over Bacteremia/DRUG THERAPY/EPIDEMIOLOGY/MICROBIOLOGY Chronic Disease Comorbidity Comparative Study Drug Resistance, Microbial English Abstract Female Human Immunocompromised Host Liver Diseases/EPIDEMIOLOGY Liver Diseases, Alcoholic/EPIDEMIOLOGY Male Middle Age Peritonitis/DRUG THERAPY/EPIDEMIOLOGY/MICROBIOLOGY Pneumococcal Infections/DRUG THERAPY/*EPIDEMIOLOGY/MICROBIOLOGY Pneumonia, Lobar/DRUG THERAPY/EPIDEMIOLOGY/MICROBIOLOGY Prognosis Retrospective Studies Streptococcus pneumoniae/DRUG EFFECTS/ISOLATION & PURIF JOURNAL ARTICLE REVIEW REVIEW, MULTICASE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response CountyCare Offers Historic Opportunity to Improve Care for People with HIV International AIDS Advocates Demand China Give $1 Billion to Global Fund Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 AHF: Global AIDS Patients, Doctors Lobby Congress on PEPFAR Reauth Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM Study Finds Vitamin C Can Kill Drug-Resistant TB CONNECTICUT: Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C Too many patients, too little time OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research: June 14, 2013 Researchers from Albert Einstein College of Medicine Report Details of New Studies and Findings in the Area of HIV/AIDS Legal help for AIDS patients
Information in this article was accurate in February 28, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.